Iron Supplements for Pregnant Women with Anemia

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

Recruiting Phase 4 Interventional Study
Iron-deficiency Anemia (IDA) Pregnancy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Southern Illinois University · Other
Who this trial is looking for

This trial is looking for pregnant women who have been diagnosed with iron deficiency anemia. Participants will take iron supplements either every day or every other day to see which method works better.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am pregnant and less than 30 weeks along.
  • I have been diagnosed with iron deficiency anemia.

You may not be able to join if

  • I am under 18 years old.
  • I have severe anemia that needs a blood transfusion.
  • I have a known blood disorder like thalassemia or sickle cell anemia.
  • I have other types of anemia, like vitamin B12 or folate deficiency.
  • I have ulcerative colitis or Crohn's disease.
  • I have gastric ulcers.
  • I have had gastric bypass surgery.
  • I have had complications during pregnancy, like abnormal placentation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Pregnant patients will be enrolled at less than 30 weeks gestational age (GA) with laboratory confirmed IDA (as defined by hemoglobin under 10.5 g/dL, as well as ferritin under 15 mcg/L) Exclusion Criteria: * Patients \<18 years old, patients who have severe IDA that require…
Contacts

Kathleen A Groesch, MS

217-545-6671

kgroesch@siumed.edu

CONTACT

Teresa S Wilson, BA

217-545-6711

twilson2@siumed.edu

CONTACT